Global Bronchodilator Market Growth 2022-2028

As the global economy mends, the 2021 growth of Bronchodilator will have significant change from previous year. According to our (LP Information) latest study, the global Bronchodilator market size is USD  million in 2022 from USD 30470 million in 2021, with a change of % between 2021 and 2022. The global Bronchodilator market size will reach USD 41580 million in 2028, growing at a CAGR of 4.5% over the analysis period.

The United States Bronchodilator market is expected at value of US$  million in 2021 and grow at approximately  % CAGR during review period. China constitutes a  % market for the global Bronchodilator market, reaching US$  million by the year 2028. As for the Europe Bronchodilator landscape, Germany is projected to reach US$  million by 2028 trailing a CAGR of  % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at  % and  % respectively for the next 5-year period.

Global main Bronchodilator players cover GlaxoSmithKline, Roche, AstraZeneca, and Boehringer Ingelheim, etc. In terms of revenue, the global largest two companies occupy a share nearly  % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Bronchodilator market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
    Short-acting Bronchodilator
    Long-acting Bronchodilator

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
    Asthma
    Chronic Obstructive Pulmonary Disease
    Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
    GlaxoSmithKline
    Roche
    AstraZeneca
    Boehringer Ingelheim
    Amgen
    Kissei Pharmaceutical
    Mitsubishi Tanabe Pharma
    Sanofi
    Theron Pharmaceuticals
    Array BioPharma
    Kyowa Hakko Kirin
    Verona Pharma
    Nycomed Pharma

List of Tables
    Table 1. Bronchodilator Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Bronchodilator Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Short-acting Bronchodilator
    Table 4. Major Players of Long-acting Bronchodilator
    Table 5. Global Bronchodilator Sales by Type (2017-2022) & (K Doses)
    Table 6. Global Bronchodilator Sales Market Share by Type (2017-2022)
    Table 7. Global Bronchodilator Revenue by Type (2017-2022) & ($ million)
    Table 8. Global Bronchodilator Revenue Market Share by Type (2017-2022)
    Table 9. Global Bronchodilator Sale Price by Type (2017-2022) & (USD/Dose)
    Table 10. Global Bronchodilator Sales by Application (2017-2022) & (K Doses)
    Table 11. Global Bronchodilator Sales Market Share by Application (2017-2022)
    Table 12. Global Bronchodilator Revenue by Application (2017-2022)
    Table 13. Global Bronchodilator Revenue Market Share by Application (2017-2022)
    Table 14. Global Bronchodilator Sale Price by Application (2017-2022) & (USD/Dose)
    Table 15. Global Bronchodilator Sales by Company (2020-2022) & (K Doses)
    Table 16. Global Bronchodilator Sales Market Share by Company (2020-2022)
    Table 17. Global Bronchodilator Revenue by Company (2020-2022) ($ Millions)
    Table 18. Global Bronchodilator Revenue Market Share by Company (2020-2022)
    Table 19. Global Bronchodilator Sale Price by Company (2020-2022) & (USD/Dose)
    Table 20. Key Manufacturers Bronchodilator Producing Area Distribution and Sales Area
    Table 21. Players Bronchodilator Products Offered
    Table 22. Bronchodilator Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Bronchodilator Sales by Geographic Region (2017-2022) & (K Doses)
    Table 26. Global Bronchodilator Sales Market Share Geographic Region (2017-2022)
    Table 27. Global Bronchodilator Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 28. Global Bronchodilator Revenue Market Share by Geographic Region (2017-2022)
    Table 29. Global Bronchodilator Sales by Country/Region (2017-2022) & (K Doses)
    Table 30. Global Bronchodilator Sales Market Share by Country/Region (2017-2022)
    Table 31. Global Bronchodilator Revenue by Country/Region (2017-2022) & ($ millions)
    Table 32. Global Bronchodilator Revenue Market Share by Country/Region (2017-2022)
    Table 33. Americas Bronchodilator Sales by Country (2017-2022) & (K Doses)
    Table 34. Americas Bronchodilator Sales Market Share by Country (2017-2022)
    Table 35. Americas Bronchodilator Revenue by Country (2017-2022) & ($ Millions)
    Table 36. Americas Bronchodilator Revenue Market Share by Country (2017-2022)
    Table 37. Americas Bronchodilator Sales by Type (2017-2022) & (K Doses)
    Table 38. Americas Bronchodilator Sales Market Share by Type (2017-2022)
    Table 39. Americas Bronchodilator Sales by Application (2017-2022) & (K Doses)
    Table 40. Americas Bronchodilator Sales Market Share by Application (2017-2022)
    Table 41. APAC Bronchodilator Sales by Region (2017-2022) & (K Doses)
    Table 42. APAC Bronchodilator Sales Market Share by Region (2017-2022)
    Table 43. APAC Bronchodilator Revenue by Region (2017-2022) & ($ Millions)
    Table 44. APAC Bronchodilator Revenue Market Share by Region (2017-2022)
    Table 45. APAC Bronchodilator Sales by Type (2017-2022) & (K Doses)
    Table 46. APAC Bronchodilator Sales Market Share by Type (2017-2022)
    Table 47. APAC Bronchodilator Sales by Application (2017-2022) & (K Doses)
    Table 48. APAC Bronchodilator Sales Market Share by Application (2017-2022)
    Table 49. Europe Bronchodilator Sales by Country (2017-2022) & (K Doses)
    Table 50. Europe Bronchodilator Sales Market Share by Country (2017-2022)
    Table 51. Europe Bronchodilator Revenue by Country (2017-2022) & ($ Millions)
    Table 52. Europe Bronchodilator Revenue Market Share by Country (2017-2022)
    Table 53. Europe Bronchodilator Sales by Type (2017-2022) & (K Doses)
    Table 54. Europe Bronchodilator Sales Market Share by Type (2017-2022)
    Table 55. Europe Bronchodilator Sales by Application (2017-2022) & (K Doses)
    Table 56. Europe Bronchodilator Sales Market Share by Application (2017-2022)
    Table 57. Middle East & Africa Bronchodilator Sales by Country (2017-2022) & (K Doses)
    Table 58. Middle East & Africa Bronchodilator Sales Market Share by Country (2017-2022)
    Table 59. Middle East & Africa Bronchodilator Revenue by Country (2017-2022) & ($ Millions)
    Table 60. Middle East & Africa Bronchodilator Revenue Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Bronchodilator Sales by Type (2017-2022) & (K Doses)
    Table 62. Middle East & Africa Bronchodilator Sales Market Share by Type (2017-2022)
    Table 63. Middle East & Africa Bronchodilator Sales by Application (2017-2022) & (K Doses)
    Table 64. Middle East & Africa Bronchodilator Sales Market Share by Application (2017-2022)
    Table 65. Key Market Drivers & Growth Opportunities of Bronchodilator
    Table 66. Key Market Challenges & Risks of Bronchodilator
    Table 67. Key Industry Trends of Bronchodilator
    Table 68. Bronchodilator Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. Bronchodilator Distributors List
    Table 71. Bronchodilator Customer List
    Table 72. Global Bronchodilator Sales Forecast by Region (2023-2028) & (K Doses)
    Table 73. Global Bronchodilator Sales Market Forecast by Region
    Table 74. Global Bronchodilator Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 75. Global Bronchodilator Revenue Market Share Forecast by Region (2023-2028)
    Table 76. Americas Bronchodilator Sales Forecast by Country (2023-2028) & (K Doses)
    Table 77. Americas Bronchodilator Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 78. APAC Bronchodilator Sales Forecast by Region (2023-2028) & (K Doses)
    Table 79. APAC Bronchodilator Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Europe Bronchodilator Sales Forecast by Country (2023-2028) & (K Doses)
    Table 81. Europe Bronchodilator Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. Middle East & Africa Bronchodilator Sales Forecast by Country (2023-2028) & (K Doses)
    Table 83. Middle East & Africa Bronchodilator Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Global Bronchodilator Sales Forecast by Type (2023-2028) & (K Doses)
    Table 85. Global Bronchodilator Sales Market Share Forecast by Type (2023-2028)
    Table 86. Global Bronchodilator Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 87. Global Bronchodilator Revenue Market Share Forecast by Type (2023-2028)
    Table 88. Global Bronchodilator Sales Forecast by Application (2023-2028) & (K Doses)
    Table 89. Global Bronchodilator Sales Market Share Forecast by Application (2023-2028)
    Table 90. Global Bronchodilator Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 91. Global Bronchodilator Revenue Market Share Forecast by Application (2023-2028)
    Table 92. GlaxoSmithKline Basic Information, Bronchodilator Manufacturing Base, Sales Area and Its Competitors
    Table 93. GlaxoSmithKline Bronchodilator Product Offered
    Table 94. GlaxoSmithKline Bronchodilator Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 95. GlaxoSmithKline Main Business
    Table 96. GlaxoSmithKline Latest Developments
    Table 97. Roche Basic Information, Bronchodilator Manufacturing Base, Sales Area and Its Competitors
    Table 98. Roche Bronchodilator Product Offered
    Table 99. Roche Bronchodilator Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 100. Roche Main Business
    Table 101. Roche Latest Developments
    Table 102. AstraZeneca Basic Information, Bronchodilator Manufacturing Base, Sales Area and Its Competitors
    Table 103. AstraZeneca Bronchodilator Product Offered
    Table 104. AstraZeneca Bronchodilator Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 105. AstraZeneca Main Business
    Table 106. AstraZeneca Latest Developments
    Table 107. Boehringer Ingelheim Basic Information, Bronchodilator Manufacturing Base, Sales Area and Its Competitors
    Table 108. Boehringer Ingelheim Bronchodilator Product Offered
    Table 109. Boehringer Ingelheim Bronchodilator Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 110. Boehringer Ingelheim Main Business
    Table 111. Boehringer Ingelheim Latest Developments
    Table 112. Amgen Basic Information, Bronchodilator Manufacturing Base, Sales Area and Its Competitors
    Table 113. Amgen Bronchodilator Product Offered
    Table 114. Amgen Bronchodilator Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 115. Amgen Main Business
    Table 116. Amgen Latest Developments
    Table 117. Kissei Pharmaceutical Basic Information, Bronchodilator Manufacturing Base, Sales Area and Its Competitors
    Table 118. Kissei Pharmaceutical Bronchodilator Product Offered
    Table 119. Kissei Pharmaceutical Bronchodilator Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 120. Kissei Pharmaceutical Main Business
    Table 121. Kissei Pharmaceutical Latest Developments
    Table 122. Mitsubishi Tanabe Pharma Basic Information, Bronchodilator Manufacturing Base, Sales Area and Its Competitors
    Table 123. Mitsubishi Tanabe Pharma Bronchodilator Product Offered
    Table 124. Mitsubishi Tanabe Pharma Bronchodilator Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 125. Mitsubishi Tanabe Pharma Main Business
    Table 126. Mitsubishi Tanabe Pharma Latest Developments
    Table 127. Sanofi Basic Information, Bronchodilator Manufacturing Base, Sales Area and Its Competitors
    Table 128. Sanofi Bronchodilator Product Offered
    Table 129. Sanofi Bronchodilator Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 130. Sanofi Main Business
    Table 131. Sanofi Latest Developments
    Table 132. Theron Pharmaceuticals Basic Information, Bronchodilator Manufacturing Base, Sales Area and Its Competitors
    Table 133. Theron Pharmaceuticals Bronchodilator Product Offered
    Table 134. Theron Pharmaceuticals Bronchodilator Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 135. Theron Pharmaceuticals Main Business
    Table 136. Theron Pharmaceuticals Latest Developments
    Table 137. Array BioPharma Basic Information, Bronchodilator Manufacturing Base, Sales Area and Its Competitors
    Table 138. Array BioPharma Bronchodilator Product Offered
    Table 139. Array BioPharma Bronchodilator Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 140. Array BioPharma Main Business
    Table 141. Array BioPharma Latest Developments
    Table 142. Kyowa Hakko Kirin Basic Information, Bronchodilator Manufacturing Base, Sales Area and Its Competitors
    Table 143. Kyowa Hakko Kirin Bronchodilator Product Offered
    Table 144. Kyowa Hakko Kirin Bronchodilator Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 145. Kyowa Hakko Kirin Main Business
    Table 146. Kyowa Hakko Kirin Latest Developments
    Table 147. Verona Pharma Basic Information, Bronchodilator Manufacturing Base, Sales Area and Its Competitors
    Table 148. Verona Pharma Bronchodilator Product Offered
    Table 149. Verona Pharma Bronchodilator Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 150. Verona Pharma Main Business
    Table 151. Verona Pharma Latest Developments
    Table 152. Nycomed Pharma Basic Information, Bronchodilator Manufacturing Base, Sales Area and Its Competitors
    Table 153. Nycomed Pharma Bronchodilator Product Offered
    Table 154. Nycomed Pharma Bronchodilator Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 155. Nycomed Pharma Main Business
    Table 156. Nycomed Pharma Latest Developments
List of Figures
    Figure 1. Picture of Bronchodilator
    Figure 2. Bronchodilator Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Bronchodilator Sales Growth Rate 2017-2028 (K Doses)
    Figure 7. Global Bronchodilator Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Bronchodilator Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Short-acting Bronchodilator
    Figure 10. Product Picture of Long-acting Bronchodilator
    Figure 11. Global Bronchodilator Sales Market Share by Type in 2021
    Figure 12. Global Bronchodilator Revenue Market Share by Type (2017-2022)
    Figure 13. Bronchodilator Consumed in Asthma
    Figure 14. Global Bronchodilator Market: Asthma (2017-2022) & (K Doses)
    Figure 15. Bronchodilator Consumed in Chronic Obstructive Pulmonary Disease
    Figure 16. Global Bronchodilator Market: Chronic Obstructive Pulmonary Disease (2017-2022) & (K Doses)
    Figure 17. Bronchodilator Consumed in Others
    Figure 18. Global Bronchodilator Market: Others (2017-2022) & (K Doses)
    Figure 19. Global Bronchodilator Sales Market Share by Application (2017-2022)
    Figure 20. Global Bronchodilator Revenue Market Share by Application in 2021
    Figure 21. Bronchodilator Revenue Market by Company in 2021 ($ Million)
    Figure 22. Global Bronchodilator Revenue Market Share by Company in 2021
    Figure 23. Global Bronchodilator Sales Market Share by Geographic Region (2017-2022)
    Figure 24. Global Bronchodilator Revenue Market Share by Geographic Region in 2021
    Figure 25. Global Bronchodilator Sales Market Share by Region (2017-2022)
    Figure 26. Global Bronchodilator Revenue Market Share by Country/Region in 2021
    Figure 27. Americas Bronchodilator Sales 2017-2022 (K Doses)
    Figure 28. Americas Bronchodilator Revenue 2017-2022 ($ Millions)
    Figure 29. APAC Bronchodilator Sales 2017-2022 (K Doses)
    Figure 30. APAC Bronchodilator Revenue 2017-2022 ($ Millions)
    Figure 31. Europe Bronchodilator Sales 2017-2022 (K Doses)
    Figure 32. Europe Bronchodilator Revenue 2017-2022 ($ Millions)
    Figure 33. Middle East & Africa Bronchodilator Sales 2017-2022 (K Doses)
    Figure 34. Middle East & Africa Bronchodilator Revenue 2017-2022 ($ Millions)
    Figure 35. Americas Bronchodilator Sales Market Share by Country in 2021
    Figure 36. Americas Bronchodilator Revenue Market Share by Country in 2021
    Figure 37. United States Bronchodilator Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Canada Bronchodilator Revenue Growth 2017-2022 ($ Millions)
    Figure 39. Mexico Bronchodilator Revenue Growth 2017-2022 ($ Millions)
    Figure 40. Brazil Bronchodilator Revenue Growth 2017-2022 ($ Millions)
    Figure 41. APAC Bronchodilator Sales Market Share by Region in 2021
    Figure 42. APAC Bronchodilator Revenue Market Share by Regions in 2021
    Figure 43. China Bronchodilator Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Japan Bronchodilator Revenue Growth 2017-2022 ($ Millions)
    Figure 45. South Korea Bronchodilator Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Southeast Asia Bronchodilator Revenue Growth 2017-2022 ($ Millions)
    Figure 47. India Bronchodilator Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Australia Bronchodilator Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Europe Bronchodilator Sales Market Share by Country in 2021
    Figure 50. Europe Bronchodilator Revenue Market Share by Country in 2021
    Figure 51. Germany Bronchodilator Revenue Growth 2017-2022 ($ Millions)
    Figure 52. France Bronchodilator Revenue Growth 2017-2022 ($ Millions)
    Figure 53. UK Bronchodilator Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Italy Bronchodilator Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Russia Bronchodilator Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Middle East & Africa Bronchodilator Sales Market Share by Country in 2021
    Figure 57. Middle East & Africa Bronchodilator Revenue Market Share by Country in 2021
    Figure 58. Egypt Bronchodilator Revenue Growth 2017-2022 ($ Millions)
    Figure 59. South Africa Bronchodilator Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Israel Bronchodilator Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Turkey Bronchodilator Revenue Growth 2017-2022 ($ Millions)
    Figure 62. GCC Country Bronchodilator Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Manufacturing Cost Structure Analysis of Bronchodilator in 2021
    Figure 64. Manufacturing Process Analysis of Bronchodilator
    Figure 65. Industry Chain Structure of Bronchodilator
    Figure 66. Channels of Distribution
    Figure 67. Distributors Profiles

    GlaxoSmithKline
    Roche
    AstraZeneca
    Boehringer Ingelheim
    Amgen
    Kissei Pharmaceutical
    Mitsubishi Tanabe Pharma
    Sanofi
    Theron Pharmaceuticals
    Array BioPharma
    Kyowa Hakko Kirin
    Verona Pharma
    Nycomed Pharma

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape